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Abstract 
The human stress response has evolved to maintain homeostasis under conditions of real or perceived 
stress. This objective is achieved through autoregulatory neural and hormonal systems in close 
association with central and peripheral clocks. The hypothalamic–pituitary–adrenal (HPA) axis is a key 
regulatory pathway in the maintenance of these homeostatic processes. The end product of this 
pathway — cortisol — is secreted in a pulsatile pattern, with changes in pulse amplitude creating a 
circadian pattern. During acute stress, cortisol levels rise and pulsatility is maintained. Although the 
initial rise in cortisol follows a large surge of adrenocorticotropic hormone (ACTH), if long-term 
inflammatory stress occurs, ACTH returns to near basal levels while cortisol remains raised as a result 
of increased adrenal sensitivity. In chronic stress, hypothalamic activation of the pituitary changes 
from corticotropin-releasing hormone dominant to arginine vasopressin dominant, and cortisol 
remains raised due at least in part to decreased cortisol metabolism. Acute elevations in cortisol are 
beneficial to promote survival of the fittest as part of the fight or flight response . However, chronic 
exposure to stress results in reversal of the beneficial effects with long-term cortisol exposure 
becoming maladaptive, which can lead to a broad range of problems, including the metabolic 
syndrome, obesity, cancer, mental health disorders, cardiovascular disease and increased 
susceptibility to infections. Neuroimmunoendocrine modulation in disease states and glucocorticoid-






The hypothalamic–pituitary–adrenal (HPA) axis is a key system that synchronises the stress response 
with circadian regulatory processes. 
Regulation of the HPA axis is very dynamic with both ultradian and circadian oscillations. 
Short term and longer-term stress result in different regulatory mechanisms involving hypothalamic, 
pituitary and adrenal activity, as well as cortisol metabolism. 
Chronic elevation and non-physiological patterns of cortisol result in poor cognitive, metabolic and 
immune function. 
[H1] Introduction 
In response to a stressor the body activates multiple co-ordinated and dynamic processes to restore 
homeostasis, preserve life and ultimately achieve evolutionary success for the species. The 
importance of endocrine systems in this homeostatic regulation has been known since the early 
studies of Hans Selye1 in the 1930s, when activation of the sympatho–adrenodedullary (SAM) and 
hypothalamic–pituitary–adrenal (HPA) axes was described in response to physical injury and exertion 
as well as perceived psychological threats. Interestingly, anticipation of these threats is itself a very 
potent activator of these systems2. Homeostatic processes also interact with internal and external 
Zeitgebers such as the light–dark cycle and internal body clocks3,4. These internal clocks enable the 
body to anticipate regular changes in the environment to ensure optimal fitness across the 24 hours 
and thus the best chance for survival5. The human stress response is an additional homeostatic 
mechanism that provides a better chance of survival when the body is under threat and mobilises 
neural and hormonal networks to optimise cognitive, cardiovascular, immunological and metabolic 
function (figure 1).  In this Review we discuss how the HPA axis helps achieve and maintain 




appropriate tissue activity at different times of the day, and faster ultradian rhythms to optimise tissue 
specific glucocorticoid signalling and maintain the rapid reactivity necessary for a stress response 
system. 
 
[H1] Circadian clocks 
In the absence of internal or external stressors, the integrity of physiological systems is maintained in 
a dynamic fashion over 24 h by an internal circadian clock that anticipates the changes occurring over 
the 24-h day. In the past, the neurocentric hierarchical view was that body rhythms were controlled 
from a master clock in the hypothalamic suprachiasmatic nucleus (SCN)6. Now, it is very clear that 
peripheral clocks also exist in most, if not all, tissues of the body, which have their own autonomous 
transcriptional autoregulatory feedback loops7. The core clock genes, both in the SCN and peripheral 
clocks, are CLOCK and BMAL1. Activation of these genes generates a heterodimer of BMAL1 with 
either CLOCK (or NPAS2) which bind at promotor elements called E-boxes to drive genes encoding 
period 1-3, cryptochrome 1-2 and nuclear receptor subfamily 1-2. The resultant proteins then 
feedback to repress BMAL1 by a series of feedback loops generating a 24-hour rhythm8,9 which allows 
time of day dependent regulation of downstream genomic pathways. This rhythmicity is crucial for 
homeostasis. The body can only behave optimally when all biological rhythms are in synchrony. 
However, with our increasingly chaotic lifestyles this orderly physiological regulation is steadily being 
disrupted, which can result in chronodisruption4,10. This desynchronization between cellular oscillators 
in the SCN and peripheral tissues can manifest as negative health outcomes in the form of 
cardiovascular, metabolic, cognitive and immune dysfunction4,10-14. 
 




The HPA is critical for life and is a major part of our homeostatic regulatory system15. The output of 
this system is the endogenous glucocorticoid corticosterone (in rodents) or cortisol (in humans), which 
are collectively referred to as CORT. Glucocorticoids have diverse and far reaching effects, which is 
why they are such successful therapeutic agents; however, this diversity is a double-edged sword and 
excess levels of glucocorticoids result in a myriad of unwanted adverse effects including diabetes, 
hypertension, immune dysregulation and osteoporosis16. Glucocorticoids exhibit powerful anti-
inflammatory functions both at a whole cell and at transcriptional level. They can induce apoptosis of 
T lymphocytes, neurotrophils, basophils and eosinophils17. They also regulate multiple 
proinflammatory genes encoding cytokines, chemokines and inflammatory enzymes associated with 
repression of AP1 and NF-Kappa B transcription18. Glucocorticoids also inhibit antigen presentation19,20 
and major histocompatibility complex class II expression21 and antibodies22, and favour T helper (TH) 1 
versus TH2 responses20. They influence cytotoxic effects via cell death and oxidative stress23, have a 
role in metabolic regulation through glucose utilisation and ATP production24 and interact with the 
major neurotransmitters and many secondary neuropeptidergic systems. As such, glucocorticoids 
modulate emotion and cognition, with key examples being learning ability, performance, emotional 
perception and mood25,26. These interactions also exemplify how glucocorticoid therapy can result in 
multiple effects including unwanted side effects such as depression27-30.  
CORT is a homeostatic anticipatory hormone that is secreted by the adrenal glands. Consequently, 
under basal conditions it is released with a characteristic circadian pattern of secretion with high levels 
just before waking (start of active cycle), followed by a steady decline down to trough (or nadir) levels 
during the sleeping or inactive phase; hence anticipating the needs of the body (figure 2A). CORT’s 
daily rhythm is regulated through indirect projections from the SCN to the paraventricular nucleus 
(PVN) of the hypothalamus, which inhibit corticotropin-releasing hormone (CRH) and arginine 
vasopressin (AVP) release during the inactive phase of the cycle31,32. Furthermore, to produce 
appropriate reactivity to physiological, cognitive and emotional stressors, the brain stem and limbic 




Axonal terminals in the median eminence release CRH and AVP into the hypophyseal portal system 
where they are transported to the pituitary and stimulate pituitary corticotrophs to release 
adrenocorticotropic hormone (ACTH). ACTH is released into the systemic circulation and once at the 
adrenal cortex stimulates the production of CORT. CORT undergoes de novo synthesis and release 
back into the systemic circulation, enabling it to travel to its target tissues and produce its 
characteristic metabolic, cardiovascular, immunological and cognitive effects33. CORT also acts via an 
autoregulatory negative feedback loop and inhibits HPA activity via effects at the level of the pituitary, 
hypothalamic PVN and hippocampus35. 
Further levels of circadian control exist, including splanchnic nerve innervation of the adrenal glands36. 
The adrenal glands receive autonomic (sympathetic) innervation via neuronal projections of the 
autonomic portion of the PVN36,37, which alters adrenal cortical sensitivity to ACTH with a reduction of 
responsiveness during the circadian nadir. CORT synthesis and adrenal clock gene functioning is also 
influenced by a light-sensitive mechanism that occurs across the 24 h period, with a shift in irradiance 
threshold according to the time of day. Thus, in animals housed in complete darkness, although high 
intensity light activated corticosterone at all times of day, lower intensity light had no effect during 
the subjective day. The adrenal response therefore is dependent on both irradiance and circadian 
phase38,39.  The adrenal gland itself also has an autonomous clock that regulates ACTH sensitivity and 
steroidogenesis, allowing it to fine tune its own homeostatic control40,41. Finally, peripheral CLOCK-
mediated acetylation of the glucocorticoid receptor can decrease tissue sensitivity to glucocorticoids 
in a circadian manner132.  
These circadian fluctuations in activation of glucocorticoid receptors also have important interactions 
with multiple other crucial homeostatic processes including the transcriptional activity of other genes 
that respond to glucocorticoids and their corresponding physiological outputs, such as physical activity 




2, a gene implicated in physical activity, temperature and emotional response has  a circadian 
rhythmicity which is abolished by exogenous steroids43.   
[H1] Stress response 
[H2] Acute stress. 
The acute response to stress is a dynamic process that changes over time, starting with stereotypic 
behaviours and then changing to goal directed behaviours specific to the stressor, followed by 
activation of the SAM within seconds and finally recruitment of the HPA axis, with peak levels of 
cortisol occurring between 15 and 20 minutes after stress onset44. These early responses provide 
increased energy resources and initiate longer term and slower genomic effects that restrain 
inflammatory and other potentially dangerous responses45. The response to the acute stress of cardiac 
surgery can be seen in Figure 2B46. This response is very interesting for several reasons. First, despite 
the greatly increased levels of cortisol, the pattern of cortisol secretion remains pulsatile. Second, 
despite initial high levels of ACTH, these rapidly fall to basal levels while the cortisol remains raised. 
Despite this fall in ACTH levels, small changes in these basal levels of ACTH initiate large pulses of 
cortisol, indicating a rapidly induced increased sensitivity of the adrenal cortex to ACTH. This effect 
has now been investigated in reverse translation studies in rats and complemented with mathematical 
modelling, which enabled the importance of the dynamic adrenal steroidogenic regulatory network 
to be characterised47. 
[H2] Chronic stress 
In response to chronic stress, a dynamic change of the ratio of AVP to CRH in the hypothalamic PVN 
occurs48 as well as an associated decreased sensitivity to glucocorticoid feedback49. Obstructive sleep 
apnoea is an excellent model of chronic stress (figure 2C). In sleep apnoea, there is a marked increase 
in the amount of cortisol released during each secretory pulse – which normalises after continuous 




with the increased levels of cortisol produced by long-term stress being present for the first few days 
secondary to increased adrenal sensitivity to ACTH and increased cortisol synthesis46. During 
prolonged critical illness, there is a further change in HPA regulation with reduced cortisol metabolism 
becoming an increasingly important factor in maintaining raised levels of plasma cortisol51,52. 
[H2] Glucocorticoid signalling  
Glucocorticoid receptors (GR) and mineralocorticoid receptors (MR) are the cognate intracellular 
nuclear receptors for CORTs53. The affinity of CORT for MR is approximately five-fold to ten-fold higher 
than that for GR54. Binding of CORT to its receptors leads to either transactivation or repression of 
genomic transcription as well as more rapid nongenomic effects55,56. Non genomic signalling is 
mediated via classic57 or membrane bound variants of the receptors58,59. The membrane bound 
variants have lower glucocorticoid affinity than their classic nuclear counterparts60. Nuclear MRs are 
generally constantly occupied during the day and only become unoccupied at the very low levels of 
CORT found at night in humans or during the day in rodents. As CORT levels rise to a critical threshold 
(as seen during the circadian peak or following an acute or chronic stress, nuclear GR and membrane 
associated MR and GR occupation occurs53. It is important to note that the one exception to this effect 
is the hypothalamic SCN, which does not appear to be regulated by circulating CORT61. As such, the 
SCN is the one place where endogenous CORT cannot shift clock function. Whether this feature is due 
to a lack of corticosteroid receptors or altered chromatin structure is unclear. 
A further level of regulatory control is the tissue specificity of GR and MR distribution. GRs are present 
throughout the brain and peripheral tissues whilst MRs have more limited localisation, predominately 
being found in cardiovascular tissue, liver and kidneys, as well as corticolimbic regions of the brain53. 
Although GR is present throughout the brain, only the hippocampus, basal ganglia, lateral septum and 
medial amygdala neurones present a high MR:GR ratio62. Since these areas do not express 11 β-
hydroxysteroid dehydrogenase (11 β-HSD) type 2 (discussed in detail in a subsequent section), MR is 




response of the lower affinity membrane-bound MR that responds when CORT levels rise in response 
to a stressor28. This response helps to prepare an individual to respond to a stressor through enhancing 
synaptic plasticity at a cellular level, which leads to a behavioural change in the form of altered 
decision making, attentional bias and risk assessment63. Although other brain areas can still respond 
to changes in CORT this will only be through their genomic and nongenomic GR64. Consequently, this 
region specificity in receptor distribution will modify corticosteroid signalling including the activation 
and termination of stress responses, and are likely to be important for promoting long-lasting adaptive 
protective mechanisms such as strategic planning, memory storage and consolidation65. 
Other layers of regulatory control arise through availability of CORT. Firstly, CORT is highly lipophilic, 
which means that under basal conditions 90% of CORT is tightly bound to the high-affinity, limited 
capacity protein carrier corticosteroid-binding globulin (CBG)66,67. Around 4–5% is loosely bound to 
albumin and the remaining 5% of CORT is ‘free’ and biologically active68. CBG levels are controlled by 
a variety of different factors such as genetic variability, liver and thyroid function, nutritional status, 
inflammation and stress. Additionally, CBG is saturated at fairly low CORT concentrations, including 
under basal (non-stressed) levels found at the circadian peak. Similarly to CORT, CBG exhibits 
homeostatic diurnal variation69, the resultant effect being a higher proportion of free (and therefore 
biologically active) CORT during the circadian peak, which accentuates the diurnal profile of free CORT 
and the response to stress. CBG also acts as a carrier to specific target sites (such as sites of 
inflammation) and even acts as a protein thermocouple releasing CORT at sites of increased 
temperature70. CBG concentrations are therefore of great importance for the bioavailabity of CORT 
and its ability to act at a tissue level71.  
The metabolic clearance of CORT occurs through two mechanisms, enzymic degradation in the 
liver71,72 and intracellular metabolism by the two iso-enzymes of 11β-HSD, which catalyse the 
interconversion of active CORT and the inert forms, cortisone (human) and 11-dehydrocorticosterone 




glucocorticoids, which amplifies the cellular actions of CORT72. It is widely expressed in liver, adipose 
tissue, muscle, pancreatic islets, adult brain, inflammatory cells and gonads73. 11β-HSD type 1 
therefore increases tissue levels of CORT and is thought to be a major factor in regulating tissue 
sensitivity to CORT, especially under conditions that can increase 11β-HSD type 1 activity such as 
visceral obesity71. In addition, 11β-HSD type 1 is thought to mediate many cognitive and metabolic 
effects of CORT excess. For instance, 11β-HSD type 1 deficiency in rodents protects against age and 
stress related cognitive decline whilst transgenic over-expression exacerbates cognitive impairment74. 
The other iso-form, 11β-HSD type 2, is a high-affinity dehydrogenase that inactivates glucocorticoids 
and is particularly important in the kidney, where it protects mineralocorticoid receptors from 
activation by the much higher concentration of cortisol72. More studies are needed to define how 
tissue ratios of cortisol and cortisone may change during stress and whether this might provide yet 
another mechanism to guard our homeostatic state.  
[H2] Ultradian rhythm 
Underlying the circadian rhythm there is a complex and dynamic ultradian rhythm comprised of 
discrete pulses of secretion of both ACTH and cortisol (figure 2A). This pulsatile pattern is produced at 
an approximate frequency of 60–90 min with increased pulse amplitude and frequency at the 
circadian peak75. Patterns of secretion are influenced by a multitude of factors including genetics, sex 
hormones, epigenetic influences, environmental stressors and age, which leads to individual 
diversity76,77. Unlike circadian rhythms, the origin of the ultradian rhythm is not from central SCN 
regulation; rodents with SCN lesions show an isolated loss of circadian rhythmicity, but the underlying 
pulsatility of CORT remains78. Nor does the ultradian rhythm arise as one would expect from a central 
hypothalamic ‘pulse generator’, as pulses of CRH do not induce downstream pulses of ACTH and 
CORT79. Mathematical modelling techniques were consequently utilised, which predicted that the 
ultradian rhythm has a sub-hypothalamic origin61. Here, a dynamic feedforward–feedback 




pituitary corticotrophs, together driving ultradian rhythmicity with a natural delay between ACTH 
activating adrenal MC2 receptors, glucocorticoid biosynthesis and cortisol release (figure 3).  This 
prediction was subsequently confirmed in our rat model61.  
The adrenal gland itself preferentially responds to oscillatory ACTH signals; in rodents whose 
endogenous ACTH is suppressed with exogenous glucocorticoids, pulsatile ACTH infusions result in 
pulsatile corticosterone secretion whereas constant ACTH infusions of the same total dose result in 
no response80. Additionally, the adrenal gland has its own internal feedforward–feedback system that 
amplifies the response to rapid changes of ACTH, sensitising the adrenal glands to oscillating levels of 
ACTH and hence alterations in CORT81.  
[H2] Impact of hormone oscillation 
Both circadian and ultradian oscillations in hormone levels matter. Between 5% and 20% of cells show 
clear circadian oscillations in mRNA levels12 and circadian fluctuations are found at almost every stage 
of gene expression82 and have been associated with important biological effects. In transgenic mice, 
if circadian peak levels of CORT are administered during a motor learning task, these mice show 
increased memory of motor skills83. This effect arises secondary to a rapid GR-mediated non-genomic 
mechanism via LIM kinase signalling that increases numbers of new neuronal spines. Low trough levels 
of CORT are then needed to retain and stabilise the memory. This retention and stabilisation involves 
‘pruning’ of old spines via a MR-mediated pathway that alters gene expression, which implies that 
circadian fluctuations are required for plasticity in learning and memory83. Indeed, clinically this 
phenomenon is nothing new as in patients taking glucocorticoid-based therapeutics and in Cushing 
syndrome, both situations with chronically elevated glucocorticoid levels and/or no oscillations, there 
are marked impairments in learning and memory25.  
What we are beginning to understand is that circadian rhythmicity is only the tip of the iceberg and 
functionally important dynamic changes are seen on a shorter time frame than simply circadian 




functioning84. Both in vitro and in vivo very different patterns of gene activation are seen depending 
on the pattern of hormone presentation85. Ultradian oscillations in glucocorticoid levels result in a 
phenomenon known as gene pulsing (figure 4A). This phenomenon is specific for the endogenous 
glucocorticoid hormones as synthetic glucocorticoids have long binding characteristics at the GR and 
cannot cycle on and off85. As CORT levels rise, as is seen in endogenous glucocorticoid pulsatility, GR 
binding and activation occurs followed by nuclear translocation, dimerization and interaction with 
deoxyribonucleic acid (DNA) glucocorticoid response elements (GRE), which initiates transcription. 
Next, rapid cycling of GR and transcription factors on and off chromatin occurs. Once CORT levels 
decline, as seen in pulse termination, GR dissociates from DNA and is released back into the 
nucleoplasm ready to rapidly respond to subsequent CORT pulses. If the same dose of CORT is used 
but presented as a constant as opposed to pulsatile pattern of presentation, genomic reactivity 
changes lead to altered transcriptional activity85,86 as well as differential gene responses (figure 4B)85. 
In addition to the classic GRE-dependent interactions, GR can also interact with a variety of other 
transcription factors and influence transcription via protein–protein interactions87,88 and chromatin 
remodelling87,89. These pattern dependent interactions have serious implications for therapeutics 
based on continuous exposure to glucocorticoids, and is likely to contribute to the adverse effects of 
these drugs16.  
Downstream, constant and pulsatile patterns of CORT result in differential neuronal and behavioural 
responses. For instance, noise stress induces neuronal activation of c-fos in the amygdala, 
hippocampus and hypothalamic PVN. Interestingly, pulse phase is crucial for this response. If the noise 
is administered during the rising phase, the c-fos response in the amygdala is increased (Figure 4C). 
This effect was paralleled by differential behavioural responses to the stressor. Importantly, the effect 
is reproducible with the pulse phase dependency pattern being recorded in aggressive and novelty 
behaviour responses to glucocorticoids,  as well as in the neuroendocrine mechanism of rapid HPA 
negative-feedback90,91. Translational human studies have found similar results (figure 4D). Healthy 




metyrapone and replacement therapy with either circadian or ultradian subcutaneous hydrocortisone 
or standard oral hydrocortisone therapy (three times a day) at the same total daily dosages exhibit 
altered cognitive and behavioural effects that are dependent on the cortisol pattern. Specifically, a 
lack of physiological pulsatility was associated with poorer quality of sleep, poorer working memory 
performance and  altered accuracy in recognition and attentional bias toward or away from emotional 
faces92.  
[H1] Stress and disease 
Stress is any stimulus that disrupts or threatens homeostatic balance. The stress response is a 
mechanism that can restore homeostatic processes and promote self-preservation through a complex 
interaction between the HPA axis, central and peripheral autonomic nervous systems and immune 
systems15. The HPA axis response to stress by rapidly releasing CORT.  As CORT is highly lipophilic it is 
not prestored in vesicles and is synthesised de novo in response to ACTH. During long-term stress a 
dissociation between ACTH and CORT secretion develops93,94, predominantly via increased adrenal 
sensitivity to ACTH47 or non-ACTH mediated mechanisms94. This effect is seen in patients undergoing 
cardiac surgery, who show a marked shift in adrenal responsiveness (figure 1)46, reverse translation 
animal studies suggest this shift arises secondary to changes in the regulation of both stimulatory and 
inhibitory intra-adrenal signalling pathways46. In models of inflammatory bowel disease and viral 
challenges, IL-6 and ACTH independent immune–adrenal pathways have also been linked to this 
dissociation95,96.  
The rapid rise in CORT seen under conditions of stress increases availability of supplemental energy 
stores by promotion of gluconeogenesis and inhibition of insulin production combined with 
vasoconstriction, which aids delivery of blood to muscles and the brain97. Centrally, CORT promotes 
decision making and alertness and stimulates cognitive functioning. CORT also has a pro-inflammatory 
effect, resulting in an increased response to infection98. Chronic exposure to stress results in reversal 




broad range of symptoms and disease states, including the metabolic syndrome, obesity, cancer, 
mental health disorders, cardiovascular disease and increased susceptibility to infections10,11,53,99,100.  
With regards to immune functioning, components of both the adaptive and innate immune system 
undergo circadian variations in levels and functionality to optimise response and recovery to a 
pathogen101. Autonomous circadian clocks are also found on different subsets of immune cells, 
including macrophages and lymphocytes102,103. CORT also has a multitude of effects on the immune 
system20. Chronic increases in CORT, either as a result of the effect of the steroid or the development 
of glucocorticoid resistance100, increases susceptibility to infection20. Chronic stress can impair GR 
function as a result of long-term exposure to the resultant release of pro-inflammatory cytokines. 
Indeed, cytokines (along with their signalling pathways including but not limited to mitogen-activated 
protein (MAP) kinases, nuclear factor-kappaB (NF-κB) and cyclooxygenase) inhibit GR function98. 
Potential mechanisms underlying this inhibition include disruption of GR translocation, GR–DNA 
binding, GR inflammatory mediator interactions and alterations in GR phosphorylation status104-106. 
Glucocorticoid resistance in turn interferes with HPA downregulation of the very same pro-
inflammatory cytokines and creates a vicious cycle. Thus, in the case of the common cold, an 
exaggerated response to the symptoms and signs of the upper respiratory tract illness is generated by 
the resultant pro-inflammatory response107.  
Long-term exposure to CORT also increases blood levels of glucose108 and stimulates adipocyte 
precursor maturation, which promotes adiposity109. Adipose tissue is now seen as an active endocrine 
gland rather than a passive energy store as it produces a wide variety of hormones and regulatory 
factors71. The levels of these factors in turn reflect the metabolic status of the adipocytes and interact 
with homeostatic connections between adipose tissue and the brain as well as other organs, which 
together control energy intake and expenditure71,110. Obesity is also linked to chronic low-grade 
inflammation107 via TNF and IL-6. TNF inhibits intracellular insulin signalling pathways and IL-6 




axis20. Studies of an increasingly common stress associated problem — sleep deprivation — confirm 
elevated nadir CORT levels, which then acts as another risk factor for insulin resistance112. 
Behaviourally, chronic sleep deprivation is associated with increased appetite and energy 
expenditure113. Chronic CORT exposure also stimulates mesolimbic reward pathways within the brain, 
leading to increased intake of palatable food such as sucrose solutions110. Additionally, increased 
feeding might be stimulated by leptin and ghrelin levels114,115. During chronic stress it is thought that 
these two hormones can no longer accurately signal caloric need116. The effect in this situation is a 
misperception of insufficient available energy stores115. This effect is in combination with increased 
pro-inflammatory cytokine levels28, which makes it is unsurprising that chronic stress and 
chronodisruption are linked with the development of metabolic complications. 
Hypercortisolaemia is also linked with affective disorders10,27. Mathematical modelling techniques 
have shown that individuals with major depressive disorder have disordered cortisol secretion with 
increased mass of cortisol in each pulse and increased pulse frequency117. Patients with major 
depressive disorder have long been known to exhibit glucocorticoid resistance in the form of 
resistance of endogenous cortisol to suppression in the dexamethasone and dexamethasone–CRH 
suppression tests118, the results of which can predict clinical outcome119. Chronic exposure to stress 
results in a degree of limbic system atrophy, a key region involved in regulation of emotion120. This 
effect is also closely interlinked with immune function; stress induced proinflammatory cytokines, 
including IL-1β, IL-6 and TNF, are implicated in depressive behaviour in rodent models of depression 
and in depressed patients100,104,121,122. The mechanisms underlying this are complex. It is possible that 
inflammation and glucocorticoid signalling may act on the same processes to cause cumulative 
damage or that the dual pro and anti-inflammatory effects of glucocorticoids disrupt the brains 
immune system in favour of inflammatory effects123. In patients with depression, decreased T cell 
availability might arise secondary to increased apoptosis sensitivity combined with impaired 
glucocorticoid responsiveness and reduced brain trafficking capacity in response to the appropriate 




induced anhedonia has been found to be directly linked to increased NF-κB activity104. Interestingly, 
antidepressants can enhance GR functioning125 and inhibit cytokine pathways126. 
These effects of glucocorticoids are usually accepted as simply being due to the high levels found in 
the blood. However, this theory might be an oversimplification. In primary hypocortisolaemia (or 
Addison disease), patients are treated with what we believe to be optimal replacement of 
hydrocortisone three times a day to mimic the circadian rhythm127,128. Despite this effort to give 
physiological replacement these patients have increased mortality as a result of cardiovascular 
disease, infectious disease and cancer and increased morbidity from fatigue and difficulties in 
concentrating129-131. This therapy fails to provide the anticipatory rise of cortisol prior to wakening and 
thus gives a shifted circadian profile while also resulting in acute nonphysiological levels of cortisol in 
the middle of the day132. Patients have altered immune responses in the form of altered circadian 
patterns of circulating monocytes and natural killer cells133, impaired natural killer cell function134 and 
hypomethylated CD4+ T cells135. In an attempt to rectify these adverse outcomes, modified and dual 
release preparations133,136,137, as well as continuous138 and pulsatile pump (The Pulses study, 
ISRCTN67193733) preparations are being trialled. Initial results are encouraging, with closer mirroring 
of circadian profiling resulting in alterations in clock gene function139 and improvements in immune 
functioning133 and quality of life133,136,140,141. These issues are not only limited to endogenous CORT, 
but also synthetic glucocorticoids16. These are some of the most widely prescribed medications142,143 
but despite their clinical efficacy over three quarters of patients experience adverse effects even at 
what would be considered a fairly low dose144,145. Chronic glucocorticoid treatment can also induce 
glucocorticoid resistance in susceptible patients with glucocorticoid responsive conditions such as 
asthma or rheumatoid arthritis146.  
[H1] Conclusions 
Homeostatic processes are dynamic and interactive. As society changes with development of a 24 h 




evolutionarily adaptive processes are in danger of becoming maladaptive. If we are to understand the 
growing epidemic of stress-related human disease, we need to go back to first principles and 
understand not only the mechanisms underlying the regulation of our patterns of physiological activity 
and hormone secretion — particularly over the important and notoriously difficult nadir period during 
sleep — but also why they are important for the maintenance of health. If we are going to aspire to 
an objective of optimal personalised medicine, we need to devise methods not only to measure 
dynamic basal patterns of hormonal metabolic and immune functioning over the whole day, but also 




Zeitgebers - Cues that entrain or synchronise the bodies 24-hour cycle  
Circadian clock – Biochemical oscillator with phases synchronised with solar time 
Circadian rhythm – Any biological process that displays an oscillation of approximately 24 hours 
Ultradian rhythm – A biological rhythm that occurs with a frequency of <24 hours 
Indirect projections – Neural pathways involving at least one relay 
Hypophyseal portal system – The microcirculation allowing transport of hypothalamic hormones to 
the pituitary gland 
Irradiance threshold – The threshold power of (solar) electromagnetic radiation need to exert an effect 
Stereotypic behaviours – Repetitive body movements that serve no biological function 
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Figure 1 | Co-ordination of central and peripheral clocks by glucocorticoids. The SCN central clock 
receives light dark signals which in turn influences HPA and SAM activity leading to circadian CORT 
production. CORT activates glucocorticoid receptors in peripheral tissues which synchronises 
peripheral clocks and downstream metabolic, cardiovascular, neuronal and immune pathways. 
Other zeitgebers such as food, temperature and social cues can also entrain or influence the 
entrainment of clocks and can alter the output of these downstream pathways.  
[Au: Please note that we need you to fill out a third party rights table for all display items that 
have been published elsewhere so that we can obtain the appropriate permissions. A link to the 
form is included in my covering email, but please let me know if you have any problems accessing 
or completing the form. Note that we cannot include unpublished findings in display items.]  
Figure 2 | Human cortisol ultradian rhythmicity under basal and stressful conditions. Cortisol is 
well known to be secreted in a circadian rhythm characterised by a nadir or quiescent phase during 
the inactive period (overnight whilst sleeping in humans). An anticipatory CORT rise occurs before 
waking followed by the circadian peak of secretion at the start of the active period. Underlying this 
rhythm, however, is a complex and dynamic ultradian rhythm consisting of pulses approximately 
every 3 hours. (A) A schematic representation of a circadian and ultradian cortisol rhythm from a 
healthy male volunteer. (B) The effect of acute stress of cardiac surgery (shaded area shows when 
coronary artery bypass grafting occurred– taken from Gibbison et al Critical Care 2015). Cortisol 
levels remain elevated throughout the sampling period. This occurs via an initial surge in ACTH, 
followed post operatively by altered adrenal sensitivity to ACTH. [Au: Are parts a and b the wrong 




part d (b here) shows the healthy volunteer? The grey area would then indicate the cardiac 
surgery – YES grey area is surgery in the original pptx slide C is the cardiac surgery (b) and D is the 
healthy volunteer (a)?] (C) The effect of chronic stress on HPA axis activity in the form of obstructive 
sleep apnoea, taken from Henley et al JCEM 2009. Here, disordered cortisol pulsatility is seen in the 
form of an increase in the number of and amount of cortisol secreted per pulse at baseline (before 
CPAP therapy), especially over the quiescent period when endogenous cortisol levels naturally fall. 
The profiles improve after 3 months of continuous positive airways pressure therapy. [Au: As per 
your figure sketch, I have asked our Art Editor to just include the top 2 panels from the original 
figure 1b – correct? yes]  
 
Figure 3 | Schematic representation of the HPA axis showing natural inbuilt adrenal delays. After 
release from the pituitary gland ACTH binds to adrenal Melanocortin 2 receptors. Here natural 
inbuilt delays occur; MC2R binding leads to increased uptake of cholesterol, the precursor for all 
steroid hormones. Cholesterol then undergoes a series of biosynthetic steps before being 
transported into mitochondria, undergoing hydroxylation and the subsequent release of cortisol into 
the circulation.  [Au: Please include a full figure legend, giving more detail on what is depicted in 
the legend.] [Au: I am unsure that is meant in the delay section of the figure – please could you 
clarify what you would like us to redraw here? E.g, by labelling the different parts. – new figure 
supplied]  
Figure 4 | Importance of gene pulsing. (A) In adrenalectomized rats, hourly pulses of corticosterone 
result in a similar pattern of association–dissociation kinetics in GR–DNA binding and downstream 
cyclic recruitment and pulsatile release of the clock gene Per1 nascent RNA. This effect is not seen 
with synthetic glucocorticoid treatment (taken from Stavreva et al NCB 2009) B) Ultradian and 
constant corticosterone treatment have different effects on transcription of Tsc22d3, a GR-regulated 
gene. Here, pulsatile presentation shows a pulsatile pattern of gene fold induction, whilst constant 
infusion induces constant RNA release (taken from Stavreva et al NCB 2009). C, control; P, induction; 
W, withdrawal. (C) Adrenalectomised rats received either pulsatile corticosterone (50 ng/ml or 
100ng/ml peaks) or constant corticosterone (12-h constant infusion clamped at 50 ng/ml). They then 
underwent a 10-minute noise stress. C-fos mRNA expression was analysed in different brain regions. 
A differential response was found in the pituitary, amygdala, hippocampus and PVN. The effect 
shown was dependent on both phase and amplitude of the glucocorticoid pulse, which suggests that 
a differential response is seen in stress circuitry depending on the pattern of exposure (taken from 




include part c from the original figure, OK? - YES] (D) Healthy male volunteers underwent a 
chemical adrenalectomy with metyrapone. In a cross over trial design they then received 
hydrocortisone replacement therapy (total daily dose 20mg) as either standard oral (three times a 
day), constant circadian subcutaneous infusion or constant pulsatile subcutaneous infusion for 5 
days. On day 5, participants underwent functional MRI whilst performing a facial recognition task 
(FERT). Blood Oxygen level Dependent (BOLD) imaging showed a differential response in attentional 
bias and recognition of emotional faces depending on whether a pulsatile or a non-pulsatile pattern 
of glucocorticoid presentation was used. Communication networks within the insula, striatum and 
amygdala also varied depending on whether the presentation was pulsatile or non-pulsatile. (taken 
from Kalafatakis et al PNAS 2018)  
